|Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.|
|PMID: 20598977 Owner: NLM Status: MEDLINE|
|BACKGROUND: The Global Registry of Acute Coronary Events (GRACE) risk score is widely recommended for risk assessment in patients with acute coronary syndrome. However, there is limited knowledge regarding the utility of this score for long-term risk prediction in unselected patients with acute chest pain and whether it might be improved by the integration of nonnecrosis biomarkers. METHODS: We calculated the GRACE risk score in 453 chest pain patients and assessed its value for risk assessment together with the additive prognostic information obtained from N-terminal pro-B-type natriuretic peptide, C-reactive protein, growth differentiation factor-15 (GDF-15), and cystatin C. RESULTS: After a median follow-up of 5.8 years, 92 patients (20.7%) had died. The GRACE risk score was significantly higher in patients who died (median 146 vs 93, P < .001) and provided a c-statistic regarding mortality of 0.78. A significant increase of the c-statistic was achieved only after addition of GDF-15 (c-statistic 0.81, P = .003) and, to a minor extent, after addition of cystatin C (c-statistic 0.81, P = .035). Assessment of the integrated discriminative improvement yielded similar results. N-terminal pro-B-type natriuretic peptide had only limited incremental prognostic value, and C-reactive protein was not predictive for outcome. CONCLUSION: The GRACE risk score allows for the prediction of mortality in chest pain patients even after almost 6 years of follow-up. However, its predictive value could be further enhanced by the addition of selected nonnecrosis biomarkers, in particular GDF-15 or cystatin C.|
|Kai M Eggers; Tibor Kempf; Per Venge; Lars Wallentin; Kai C Wollert; Bertil Lindahl|
Related Documents :
|8179137 - Angiotensinamide in the treatment of probable anaphylaxis to succinylated gelatin (gelo...
11903027 - Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a ra...
3403817 - Long-term outcome in patients with inferior myocardial infarction and complete atrioven...
3258227 - Phrenic nerve function and its relationship to atelectasis after coronary artery bypass...
9626277 - Clinical efficiency tools improve stroke management in a rural southern health system.
16473787 - Pulmonary parasitosis: applied clinical and therapeutic issues.
|Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't|
|Title: American heart journal Volume: 160 ISSN: 1097-6744 ISO Abbreviation: Am. Heart J. Publication Date: 2010 Jul|
|Created Date: 2010-07-05 Completed Date: 2010-08-17 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: United States|
|Languages: eng Pagination: 88-94 Citation Subset: AIM; IM|
|Copyright (c) 2010 Mosby, Inc. All rights reserved.|
|Department of Medical Sciences, Cardiology, Uppsala University Hospital and Uppsala Clinical Research Center, Uppsala, Sweden. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Acute Coronary Syndrome
Aged, 80 and over
Biological Markers / blood
C-Reactive Protein / metabolism*
Chest Pain / diagnosis*, epidemiology, etiology
Coronary Care Units
Growth Differentiation Factor 15 / blood
Natriuretic Peptide, Brain / blood*
Necrosis / blood
Peptide Fragments / blood*
Risk Assessment / methods*
Salivary Cystatins / blood
Severity of Illness Index
Sweden / epidemiology
Troponin I / blood*
|0/Biological Markers; 0/Growth Differentiation Factor 15; 0/Peptide Fragments; 0/Protein Precursors; 0/Salivary Cystatins; 0/Troponin I; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain; 9007-41-4/C-Reactive Protein|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gender differences in time to presentation for myocardial infarction before and after a national wom...
Next Document: Chronic obstructive pulmonary disease after myocardial infarction in the community.